Calypte Biomedical Corp

Endorse Company
Calypte Biomedical Corporation develops in vitro testing products to improve the diagnosis of Human Immunodeficiency Virus (HIV) infection, sexually transmitted diseases and other chronic diseases. Our innovative product line includes both point-of-case rapid tests and traditional ELISA/EIA diagnostic tests. Calypte also offers a broad range of recombinant proteins and antigens as well as proprietary reagents, buffers, and other specialty products to researchers seeking to develop and optimize immunodiagnostic assays. These unique products are based on technologies developed by Calypte scientists and are used throughout our range of in vitro diagnostic tests.